Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Shares Outstanding (Diluted Average): 2018-2024

Historic Shares Outstanding (Diluted Average) for Organogenesis Holdings (ORGO) over the last 7 years, with Dec 2024 value amounting to $131.7 million.

  • Organogenesis Holdings' Shares Outstanding (Diluted Average) fell 2.30% to $130.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.8 million, marking a year-over-year decrease of 2.30%. This contributed to the annual value of $131.7 million for FY2024, which is 0.81% down from last year.
  • Per Organogenesis Holdings' latest filing, its Shares Outstanding (Diluted Average) stood at $131.7 million for FY2024, which was down 0.81% from $132.7 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Shares Outstanding (Diluted Average) registered a high of $133.7 million during FY2021, and its lowest value of $111.4 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $132.4 million (2022), whereas its average is $132.3 million.
  • Per our database at Business Quant, Organogenesis Holdings' Shares Outstanding (Diluted Average) increased by 20.03% in 2021 and then decreased by 0.96% in 2022.
  • Over the past 5 years, Organogenesis Holdings' Shares Outstanding (Diluted Average) (Yearly) stood at $111.4 million in 2020, then rose by 20.03% to $133.7 million in 2021, then fell by 0.96% to $132.4 million in 2022, then climbed by 0.27% to $132.7 million in 2023, then declined by 0.81% to $131.7 million in 2024.